What will be the growth of the Western Blotting Market in the USA until 2026?

Comments · 40 Views

The global key manufacturers of Western Blotting include Thermo Fisher Scientific, Bio-Rad Laboratories, GE Healthcare, BD Biosciences, Merck Millipore, Sigma-Aldrich Corporation, PerkinElmer, Roche Applied Science and ProteinSimple, etc.

Expected Revenue Growth:

[275 Pages Report] The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711

What This Report Will Provide?

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global western blotting market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and assess market growth prospects.

Major Growth Boosters:

Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

Covid-19 Impact on the Global Western Blotting Market

The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. Because of the pandemic, companies have scaled up their operations for testing and tracking the infection. This provides a chance for growth in profits for companies operating in the NGS and PCR markets.

Regional Growth Analysis:

Asia Pacific region accounted for the fast growing region of the western blotting market. . The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bio clusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.

Key Market Players

Some of the leading players operating in the western blotting market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany).

Recent Developments

  • In September 2021, PerkinElmer, Inc. (US) acquired BioLegend (US), a leading provider of life science antibodies and reagents, including primary antibodies and western blot secondary reagents. This acquisition enhances the company’s existing western blotting product portfolio.
  • In August 2021, Abcam Plc (UK) acquired BioVision Inc. (US), a global supplier of life science research tools for research, diagnostics, and drug discovery. The company is a leading provider of biochemical and cell-based assays and produces a wide portfolio of other products, including recombinant proteins, antibodies, enzymes, and biochemical compounds for immunoassay technologies such as western blotting
  • In April 2021, Bio-Techne Corporation (US) launched Abby, a next-generation chemiluminescence system that automates traditional western blotting

Frequently Asked Questions (FAQ):

  1. What is the current size of the global western blotting market?
  2. Who are the leading players in the western blotting market?
  3. What are the major application segments of the western blotting market?
  4. What are the major drivers of the western blotting market?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/western-blotting-market.asp

Visit Our Web Site: https://www.marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/western-blotting.asp

Read more
Comments